Reuters logo
BRIEF-Prometic receives clearance to initiate Plasminogen diabetic foot ulcer mid-stage clinical trial
October 26, 2017 / 11:24 AM / a month ago

BRIEF-Prometic receives clearance to initiate Plasminogen diabetic foot ulcer mid-stage clinical trial

Oct 26 (Reuters) - Prometic Life Sciences Inc

* Prometic receives clearance from the Swedish Medical Products Agency to initiate Plasminogen diabetic foot ulcer mid-stage clinical trial Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below